Actionable news
0
All posts from Actionable news
Actionable news in SRPT: Sarepta Therapeutics, Inc.,

Sarepta Therapeutics Inc.

GO

Average Recommendation: Overweight Average Target Price: 45.58
Number of Ratings: 14 Current Quarters Estimate: -1.19
FY Report Date: 12 / 2015 Current Year's Estimate: -4.90
Last Quarter's Earnings: -1.25 Median PE on CY...

More